Menu

Maternal Response to Zika Damages Mouse Fetuses

Signaling pathways triggered by the mother’s immune system may cause complications during fetal development.

Jan 5, 2018
Catherine Offord

Mouse fetuses developing in Zika-infected mothers with normal immune signaling showed stunted growth and other abnormalities (right). By contrast, fetuses lacking key immune signaling proteins showed more normal development (left). SCI. IMMUNOL. 3, EAAO1680, 2018Some of the developmental damage observed in Zika-infected fetuses may be caused by the maternal immune system, according to a study published today (January 5) in Science Immunology. Researchers at Yale University found that mouse fetuses deprived of immune proteins known as interferon alpha/beta receptors (IFNARs) racked up fewer complications when their mothers were infected with the Zika virus than those with normally functioning proteins.

“We thought the fetuses missing this interferon receptor would be more susceptible to death from Zika infection,” study coauthor Akiko Iwasaki, a Yale immunologist, tells reporters, according to HealthDay News. “What we found was quite the opposite. . . . The fetuses unable to respond to interferon survived infection, and those that had the receptor, either they all died or were very small.”

IFNARs are activated by type I interferons (IFNs), antiviral proteins released by the mother’s immune system upon viral infection. Previous research in humans has suggested that the loss of IFNARs, and the subsequent pathway trigged by IFN signaling, is associated with greater susceptibility to Zika infection—indeed, the IFNAR-deficient fetuses in this study showed higher viral loads.

But the Yale team found that IFN signaling in mouse models also led to complications such as impaired development and death. What’s more, when the researchers activated the same pathway in cultured human placental tissue, they found deformities such as “knots”—abnormal structures associated with pregnancy-related pathologies. In short, “IFNAR-mediated pathology outweighed the benefit of IFNAR-dependent control of viral replication,” the authors write.

The team also discovered that the pathway triggered by IFNAR was dangerous to the fetus even in the absence of Zika infection, pointing to a possible role for the pathway in other types of problems during pregnancy. “The effects of IFN on the developing placenta likely have implications for pregnancy complications beyond ZIKV,” the team writes in the paper. “Our study implicates type I IFNs as a possible common culprit for virus-associated pregnancy complications and suggests blockade of type I IFNs as a possible intervention.” 

April 2019

Will Car T Cells Smash Tumors?

New trials take the therapy beyond the blood

Marketplace

Sponsored Product Updates

Getting More Consistent Results by Knowing the Quality of Your Protein
Getting More Consistent Results by Knowing the Quality of Your Protein
Download this guide from NanoTemper to learn how to identify and evaluate the quality of your protein samples!
Myth Busting: The Best Way to Use Pure Water in the Lab
Myth Busting: The Best Way to Use Pure Water in the Lab
Download this white paper from ELGA LabWater to learn about the role of pure water in the laboratory and the advantages of in-house water purification!
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu's New Nexera UHPLC Series with AI and IoT Enhancements Sets Industry Standard for Intelligence, Efficiency and Design
Shimadzu Corporation announces the release of the Nexera Ultra High-Performance Liquid Chromatograph series, incorporating artificial intelligence as Analytical Intelligence, allowing systems to detect and resolve issues automatically. The Nexera series makes lab management simple by integrating IoT and device networking, enabling users to easily review instrument status, optimize resource allocation, and achieve higher throughput.
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
IDT lowers genomic barriers with powerful rhAmpSeq™ targeted sequencing system
Increasing accuracy and reducing cost barriers, IDT’s innovative system delivers simple and cost-effective amplicon sequencing